CNSide Diagnostics
Healthcare Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Cnside Diagnostics Llc's Lab, Houston, T...Website
www.cnside-dx.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About CNSide Diagnostics
CNSide Diagnostics, LLC is dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays, specifically the CNSide CSF assay, designed for patients with Leptomeningeal Metastases. This innovative platform provides healthcare providers with valuable insights through the quantitative analysis and molecular characterization of tumor cells, enhancing patient care and treatment decisions. The company operates a CLIA-registered lab in Houston, Texas, focusing on improving patient outcomes with cutting-edge diagnostics. Their mission is to revolutionize the management of patients suffering from Leptomeningeal Metastases by delivering sensitive and definitive diagnostic solutions.Explore more
Popular SearchesCNSide Diagnostics LLCSIC Code 80,807NAICS Code 62,621Show moreCNSide Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CNSide Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CNSide Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if CNSide Diagnostics is spiking on competitors!
Funding: Get notified immidiatlly once CNSide Diagnostics has new funding data
Check if CNSide Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at CNSide Diagnostics
Click to see if CNSide Diagnostics had a recent Job posting/layoffs
Earning: See what the market has to say on CNSide Diagnostics recently announced quarterly report
Product Launch: Get notified when CNSide Diagnostics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
CNSide Diagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
CNSide Diagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about CNSide Diagnostics.
CNSide Diagnostics Tech Stack
A closer look at the technologies used by CNSide Diagnostics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Partnership, Medical Research
Person-Based
Branding, Corporate Strategy
Person-Based
CNSide Diagnostics News & Media
Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide® Contracted Coverage to Approximately 158 Million Covered Lives
Cerenome secures in-network agreement with BCBS Michigan, expanding CNSide’s contracted coverage to approximately 158 million covered lives.Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), today announces the appointment of Samantha Fowlkes as Vice President Head of Commercial Sales. Samantha will lead the commercial expansion of CNSide®, strengthening relationships across the oncology and pathology communities, and accelerate adoption of the CNSide platform by physicians and health systems.Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
Capital will support continued CNSide® commercial scale-up and developmentCerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives
Cerenome signs in-network agreement with HCSC, expanding CNSide contracted coverage to ~153 million lives and exceeding its 2026 coverage goal.
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding CNSide Diagnostics
Sign Up For FreeTo access detailed company insights
CNSide Diagnostics, LLC is dedicated to developing and commercializing proprietary clinical diagnostic laboratory assays, specifically the CNSide CSF assay, designed for patients with Leptomeningeal Metastases. This innovative platform provides healthcare providers with valuable insights through the quantitative analysis and molecular characterizat... Read More
